Last reviewed · How we verify

NCT03523494

Feasibility of Lymph Edema-induced Reticulation Subtraction Based on Computerized Tomography

Completed Last updated 8 March 2019
What this trial tests

trial in Lymphedema in 24 participants. Completed in 30 March 2018.

Timeline
1 January 2017
Primary endpoint
30 March 2018
30 March 2018

Quick facts

Lead sponsorUlsan University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date1 January 2017
Primary completion30 March 2018
Estimated completion30 March 2018
Sites1 location across South Korea

Conditions studied

Sponsor

Ulsan University Hospital

Who can join

Eligibility, any sex, with Lymphedema or Secondary Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Development of lympho-proliferation reticulation quantification using CT.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of a novel algorithm quantitatively estimating epifascial fibrosis in three-dimensional computed tomography images to other clinical lymphedema grading methods.
    Koo KI, Ko MH, Lee Y, Son HW, et al · · 2019 · cited 6× · PMID 31821335 · DOI 10.1371/journal.pone.0224457

Verify or expand the search:

Other recruiting trials for Lymphedema

Currently open trials in the same condition.

Other Ulsan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03523494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing